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Brevetoxins are produced by the marine
dinoflagellate Karenia brevis. K. brevis pro-
duces lipid-soluble polyether toxins, which are
ﬁltered by bivalves that are in turn consumed
by humans, resulting in neurotoxic shellfish
poisoning (NSP). Common symptoms of
NSP include gastrointestinal disorders, per-
ceived temperature reversal, paresthesia of the
mouth and extremities, tachycardia, and a lack
of motor coordination. Brevetoxins, along
with the structurally and functionally related
ciguatoxins, elicit these responses by activating
voltage-gated sodium channels in nerve, heart,
and muscle tissues (Wang and Wang 2002).
K. brevis produces type A and type B brevetox-
ins, which differ in the flexibility of their
respective backbone structures. Type A breve-
toxins include the congeners PbTx-1, -7, and
-10, while type B brevetoxins include the con-
geners PbTx-2, -3, -5, -6, -8, and -9. These
different backbone structures result in differing
efﬁcacies of the congeners in biologic systems
(Trainer et al. 1990).
Fish are highly susceptible to brevetoxins
during K. brevis blooms (Catterall and Risk
1980). Reports of fish kills have been
recorded as far back as 1530 (Taylor 1917).
The route of exposure to brevetoxins can be
either through ingestion of K. brevis cells, fol-
lowed by absorption of the toxin across the
intestine, or absorption of toxin across the gill
epithelium from lysed cells in the water
(Landsberg 2002). Brevetoxin exposure may
also occur at various levels of the food web via
trophic transfer (Tester et al. 2000). Exposure
of adult ﬁsh to brevetoxins can result in death.
Fish that survive brevetoxin exposures are able
to depurate some of the toxins via the biliary
route and other metabolic processes (Kennedy
et al. 1992). However, not all of the toxin is
eliminated; it can be found in tissues of
exposed ﬁsh and is able to transfer through the
food web (Tester et al. 2000; Washburn et al.
1994). Common symptoms of brevetoxin tox-
icity in ﬁsh include spinal curvature, corkscrew
swimming, loss of equilibrium, and convul-
sions before death (Kennedy et al. 1992; Stuart
and Baden 1988).
At nonlethal doses, an orally administered
type B brevetoxin (PbTx-3) appears in two tis-
sue compartments in ﬁsh: 40% in the liver and
nearly 30% in the muscle mass (Washburn
et al. 1994). Although brevetoxin sequestered
in tissue may not be immediately bioavailable,
because of the lipophilic nature of the toxin it
can be mobilized during oogenesis (Ungerer
and Thomas 1996a). Hence, an indirect route
of exposure may exist as the maternal transfer
of toxins from the exposed ﬁsh to its oocytes.
Embryonic and juvenile animals of many gen-
era are often more sensitive to toxicants than
their adult counterparts because they are
undergoing development at this time (Walker
et al. 1996). For this reason, we have decided
to analyze the effects of PbTx-3 as it is trans-
ferred through the maternal exposure route in
ﬁnﬁsh.
The maternal transfer of toxins can be
mimicked in vivo using a modiﬁcation of the
microinjection methods described by Walker
et al. (1996). In previous egg microinjection
studies with ciguatoxins and a type A breve-
toxin (PbTx-1), we determined microinjec-
tion to be an effective means of delivering
known amounts of toxin to individual fish
eggs (Edmunds et al. 1999; Kimm-Brinson
and Ramsdell 2001). In these studies, the
Japanese rice fish, medaka (Oryzias latipes),
was used as the experimental animal.
Although the Japanese medaka is a fresh-
water species that would not normally come
into contact with marine toxins, it has proven
to be an excellent developmental model with
well-characterized life stages. Furthermore,
medaka are easy to maintain, and breeding
can be induced and regulated in these fish
(Shi and Faustman 1989). By injecting lipid-
soluble marine toxins of known concentra-
tions into medaka eggs, we hope to shed light
on the effects of these toxins on the develop-
ment and survival of ﬁnﬁsh. In this study, we
hypothesized that PbTx-3 would elicit adverse
effects on finfish development and that it
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Brevetoxins are produced by the red tide dinoﬂagellate Karenia brevis. The toxins are lipophilic
polyether toxins that elicit a myriad of effects depending on the route of exposure and the target
organism. Brevetoxins are therefore broadly toxic to marine and estuarine animals. By mimicking
the maternal route of exposure to the oocytes in ﬁnﬁsh, we characterized the adverse effects of the
type B brevetoxin brevetoxin-3 (PbTx-3) on embryonic fish development and survival. The
Japanese rice ﬁsh, medaka (Oryzias latipes), was used as the experimental model in which individual
eggs were exposed via microinjection to various known concentrations of PbTx-3 dissolved in an oil
vehicle. Embryos injected with doses exceeding 1.0 ng/egg displayed tachycardia, hyperkinetic
twitches in the form of sustained convulsions, spinal curvature, clumping of the erythrocytes, and
decreased hatching success. Furthermore, ﬁsh dosed with toxin were often unable to hatch in the
classic tail-first fashion and emerged head first, which resulted in partial hatches and death. We
determined that the LD50 (dose that is lethal to 50% of the ﬁsh) for an injected dose of PbTx-3 is
4.0 ng/egg. The results of this study complement previous studies of the developmental toxicity of
the type A brevetoxin brevetoxin-1 (PbTx-1), by illustrating in vivo the differing afﬁnities of the
two congeners for cardiac sodium channels. Consequently, we observed differing cardiovascular
responses in the embryos, wherein embryos exposed to PbTx-3 exhibited persistent tachycardia,
whereas embryos exposed to PbTx-1 displayed bradycardia, the onset of which was delayed. Key
words: brevetoxin, development, icthyotoxicity, red tide, sodium channels. Environ Health Perspect
111:1920–1925 (2003). doi:10.1289/ehp.6386 available via http://dx.doi.org/ [Online
22 September 2003]would negatively affect survival, leading to an
overall reduction in larval recruitment.
Materials and Methods
Animals. Breeding sets (six females and four
males) of wild-type medaka (Oryzias latipes)
were obtained from Carolina Biological Supply
(Burlington, NC). Fish were housed in 2-gallon
aquaria in a balanced salt solution (17 mM
sodium chloride, 0.4 mM potassium chloride,
0.2 mM calcium chloride, 0.3 mM magnesium
sulfate, 0.24 mM sodium bicarbonate) under a
16:8-hr light:dark cycle. Water temperatures
were maintained at 25–28°C and declined
approximately 3°C during the dark cycle due to
the lack of light. This provided optimal breed-
ing conditions for the ﬁsh. Medaka were fed a
diet of either Wardley’s Spirulina Plus flake
food (Aquarium Parts West, Burbank, CA) or
live Artemia, twice daily.
Eggs were collected from the female fish
each morning and inspected for fertilization.
Healthy eggs were embedded in 2% agarose
dissolved in 12.5% Hank’s solution for stabi-
lization during microinjection. Embedding
and injections occurred 6–8 hr postfertiliza-
tion. After injection, each egg was rinsed for
approximately 1 min in 12.5% Hanks solu-
tion and then transferred to one well in a ster-
ile 24-well plate (Corning; Fisher Scientific,
Pittsburgh, PA) containing Yasamoto’s solu-
tion (133 mM NaCl, 2.7 mM KCl, 2.1 mM
CaCl2, 0.2 mM NaHCO3, pH 7.3). Egg trays
were maintained under the same light and
temperature regimen as the adult ﬁsh.
Microinjection tools. Aluminosilicate
micropipettes (outer diameter, 1 mm; Sutter
Instrument Co. Novato, CA) were pulled
using a P-87 Sutter micropipette puller and
beveled with a BV-10 Sutter micropipette
beveler. Each pipette was coated in Sigmacote
(Sigma, St. Louis, MO) to increase durability
and reduce clogging. Micropipettes were set in
a three-dimensional manipulator (MO-150;
Narashige Group, Long Island, NY) and
front-loaded with triolein oil (Sigma) vehicle
by means of a nitrogen gas picoinjector (PL1-
100; Harvard Apparatus, Holliston, MA). All
injections were carried out and visualized with
the aid of a stereomicroscope (MZ 12; Leica
Microsystems, Chantilly, VA), as were devel-
opments of the fish embryos. Digital images
were captured using an RGB Automaticam
(A209; MicroImage Video Systems Co.,
Boyertown, PA) mounted onto the micro-
scope. Images were enhanced using Flashpoint
128 video frame-grabbing software (Integral
Technologies Inc., Indianapolis, IN).
Microinjections. Brevetoxin congeners
PbTx-1 and PbTx-3 (Calbiochem, La Jolla,
CA) were dissolved in methanol and then
added to triolein oil. Once the toxin was
added to the oil, the methanol was removed
by evaporation under a stream of nitrogen,
resulting in a ﬁnal concentration of 3 µg/µL
brevetoxin in oil. PbTx-3 was administered as
one of eight doses, wherein each dose covered
a 1-ng range from 0 to 6 ± 0.5 ng/egg. A ﬁnal
dose range of 8.5 ± 1.5 ng/egg was also
administered. PbTx-1 was administered as a
single dose (3.5 ± 0.5 ng/egg), which has pre-
viously been demonstrated to elicit toxic
effects (Kimm-Brinson and Ramsdell 2001).
PbTx-1 injections were administered in order
to verify that observations between scientists
were consistent and to further compare the
effects of these toxins in vivo. Following injec-
tion, the diameter of each droplet was meas-
ured using an ocular micrometer, and the
volume was determined based on the diame-
ter of the injected droplet. Because the con-
centration of the toxin in oil was known to be
3µ g/µL, the amount injected into each indi-
vidual egg could then be determined. For
each dose range of PbTx-3, at least 10 eggs
were injected. For the single-dose PbTx-1
group, 30 eggs were injected. The amount of
toxin loaded into each egg was determined
volumetrically. To conﬁrm that there were no
artifactual effects resulting from exposure to
the vehicle (triolein oil), 10 eggs were also
injected with equivalent volumes of toxin-free
oil in parallel to each dose range (Table 1).
Finally, eggs were reared without injection to
act as a control for the vehicle-injected eggs.
Injected embryos were allowed to grow
for 13 days before being removed from the
study. The developing fish were monitored
for physical abnormalities, bradycardia, tachy-
cardia, hyperkinetic twitches, and hatching
success. We analyzed three end points to
characterize the extent of the toxic effects of
PbTx-3 on embryonic fish development:
heart rate, hyperkinetic twitches, and death.
Heart rate (beats per minute) was observed
and recorded for each embryo on days 4 and
6 after injection. Observations were delayed
until 4 days after injection to ensure the
development of a strong heart beat. In addi-
tion, hyperkinetic twitches were observed on
the same days and were recorded as the per-
centage of time the embryos twitched within
a 3-min period. On day 13, we recorded the
final status of each fish as hatched, non-
hatched, partially hatched, or dead. Medaka
normally hatch from the egg tail ﬁrst, approx-
imately 10 days after fertilization. The pres-
ence of partially hatched fish was a result of
the embryos emerging head ﬁrst from the egg
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Table 1. Minimum number of eggs injected for each dose with PbTx-3, PbTx-1, or vehicle (triolein oil). 
0.5 ± 0.5 1.5 ± 0.5 2.5 ± 0.5 3.5 ± 0.5 4.5 ± 0.5 5.5 ± 0.5 6.5 ± 0.5 8.5 ± 1.5
Noninjected 10 10 10 10 10 10 10 10
Vehicle 10 10 10 10 10 10 10 10
PbTx-3 10 10 10 10 10 10 10 10
PbTx-1 0 0 0 30 0 0 0 0
Vehicle injections were volumetric equivalents to PbTx-1 and PbTx-3 doses.
Figure 1. Still frame of a medaka embryo (80×)
injected with 3.14 ng PbTx-3 after 6 days of devel-
opment. Abbreviations: IO, injected droplet; NO,
natural oil droplet. Bar = 150 µm.
Figure 2. Still frame of a medaka embryo (80×)
injected with 3.14 ng PbTx-3. This ﬁsh has hatched
partially with the head-ﬁrst orientation and is now
trapped by the chorion. Abbreviations: IO, injected
droplet; NO, natural oil droplet. Bar = 167.5 µm.
Figure 3. Still frame of a medaka embryo (80×)
injected with 2.5 ng PbTx-3. This ﬁsh has clumped
erythrocytes, which are indicated by arrows along
the surface of the yolk. The clotting of blood in ﬁsh
dosed with toxin causes the heart to beat without
observable blood ﬂow. Bar = 100 µm. and getting trapped in the chorion. Larval
survivability was not examined because of
complications in rearing the medaka fry.
Data analysis. By measuring the diameter
of the injected oil droplets with an ocular
micrometer, the volume and thus the concen-
tration of injected toxin could be calculated.
From the concentration ranges, we deter-
mined the LD50 (dose lethal to 50% of the
fish) based on the percentage of embryos
that died, using Graphpad Prism software
(Graphpad Software Inc., San Diego, CA).
Heart rate was the most consistently observ-
able and quantifiable response we observed.
In analyzing the cardiovascular responses of
the embryos, we used a Dunnett’s multiple
comparisons test to determine if there were
significant differences between the different
volumes of vehicle injected into the control
animals compared with the noninjected eggs.
Because no differences were observed in
embryos dosed with any volume of nontoxic
vehicle, those receiving the highest dose
(8.5 ± 1.5 ng/egg) of oil, which we assume
would elicit the greatest artifactual response,
represented the control group for the eggs
injected with toxin. Subsequent statistical
analyses compared this vehicle-injected group
with eggs treated with different doses of toxin
using the Dunnett’s multiple comparisons
test, as described above. Statistical analyses
were conducted using JMP software (SAS
Institute Inc., Cary, NC).
Results
Microinjection of varying concentrations of
PbTx-3 into ﬁsh eggs (Figure 1) resulted in a
myriad of adverse effects, including tachy-
cardia, sustained convulsions, and head-first
hatching (Figure 2). Clumping of erythrocytes
(Figure 3) and spinal curvature occurred more
sporadically and were therefore not analyzed
statistically. No signiﬁcant differences existed
between the responses of the noninjected
embryos and those injected with any of the
volumes of vehicle (triolein oil). Therefore,
data collected from embryos receiving the
highest equivalent dose (8.5 ± 1.5 ng/egg) of
vehicle were designated as the control for the
PbTx-3 treatments. In eggs dosed with < 1 ng
of PbTx-3, the embryos behaved similarly to
those injected with vehicle or nothing at all,
indicating no adverse effect of the toxin. On
embryonic day 6, there was a significant
increase in heart rate for doses of PbTx-3
exceeding 1 ng/egg (Figure 4). Over the full
range of exposure doses, increases in PbTx-3
resulted in tachycardia. Tachycardia was also
observed in the PbTx-3–injected embryos on
day 4 (data not shown), following the same
dose-dependent patterns as seen on day 6
(Figure 4). This suggests that the increase in
heart rate was experienced throughout develop-
ment. Furthermore, there was no difference in
the heart rates of embryos exposed to vehicle
and to ≤ l ng PbTx-3, nor were there any dif-
ferences in the heart rates of embryos injected
with varying volumes of vehicle on either day 4
or day 6. In contrast with PbTx-3, single-dose
injections of PbTx-1 resulted in a delayed
bradycardic response on day 6 (Figure 5). As
with previous studies of PbTx-1, we observed
no effects of PbTx-1 on heart rate on day 4
(Kimm-Brinson and Ramsdell 2001).
A second effect of PbTx-3 on ﬁsh develop-
ment was observed in the form of sustained
convulsions or seizures. These were quantiﬁed
as the percentage of time (3 min) spent in
hyperkinesis. Twitching was observed and
recorded on the same days as heart rate; how-
ever, only data from day 6 are presented
(Figure 6). Similarly to the heart rate effects,
no twitches were observed in ﬁsh administered
<1   ng PbTx-3 or any of the controls. For all
other doses, twitch duration decreased with
increasing concentrations of PbTx-3 in a dose-
dependent fashion. However, as doses of toxin
increased, so did early deaths within each
treatment group, which may have added vari-
ability to the recordings at our higher doses.
Finally, death was monitored as the per-
centage of each treatment group that died
after 13 days of embryonic development, thus
indicating the effects of the toxin on hatching
success. One of the adverse effects of breve-
toxin is that it causes the fish to hatch head
first (Figure 3), whereas a healthy fish will
hatch tail ﬁrst. Many ﬁsh that break through
the chorion head first are unable to fully
remove themselves from the egg, becoming
trapped, or some may experience tearing of
the skull or eyes. Therefore, fish that were
only able to hatch partially from the egg were
classified as dead. Because recordings of
deaths also provided a dose-dependent
response, we were able to determine an LD50
for PbTx-3 of approximately 4.0 ng/egg
(Figure 7). Although death was observed in
some embryos in each of the three treatment
groups (noninjected, vehicle injected, and
PbTx-3 injected), for reasons ranging from
fungal infection to poor egg health, a clear
dose-dependent response was observed in the
medaka as concentrations of injected PbTx-3
increased.
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Figure 4. Comparative analysis of heart rate on
postfertilization day 6 (PFD6; beats/minute ± SD)
measured at each dose range for ﬁsh injected with
PbTx-3 or volumetric equivalents of vehicle. NI,
noninjected eggs. n = 10 at the time of injection for
all dose groups. A Dunnett’s multiple comparisons
test was used to test for signiﬁcant differences.
Figure 5. Comparative analysis of heart rate
(beats/minute ± SE) for eggs injected with PbTx-1,
vehicle, or PbTx-3, or noninjected eggs (NI), on
postfertilization day 6. PbTx-1 injections resulted in
bradycardia, whereas PbTx-3 injections resulted in
tachycardia. n = 10 at the time of injection for all
dose groups except PbTx-1, for which n = 30.
*Signiﬁcantly different from the control (Dunnett’s multiple
comparisons test).
Figure 6. Sustained convulsions observed on post-
fertilization day 6 in fish injected with PbTx-3.
Convulsions were quantified as the percentage of
a 3-min time interval during which twitching was
observed. No vehicle-treated fish displayed the
twitch behavior. n = 10 at the time of injection for
each dose group.
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Figure 7. Dose response of medaka mortality
expressed as a percentage for each PbTx-3 dose
at the end of the 13-day developmental period.
Vehicle-treated embryos are represented as a
dose of 0 ng/egg. LD50 = 4 ng/egg.
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This study provides insight into the develop-
mental toxicity of one of the most prevalent
brevetoxins likely to accumulate in ﬁsh (Plakas
et al. 2002; Tester et al. 2000). Although K.
brevis cells are able to produce several breve-
toxin congeners, PbTx-2 and PbTx-3 are the
most common (Plakas et al. 2002; Poli et al.
1986). Therefore, certain congeners are more
likely to accumulate in ﬁsh than others, thus
limiting potential embryonic exposure to only
a few brevetoxin subtypes. Additionally, this
investigation of both type A and type B breve-
toxins in the same experimental model per-
mits an in vivo analysis of our recent study in
which cloned heart sodium channels showed
strong affinity for type A brevetoxins over
type B brevetoxins (Bottein Dechraoui and
Ramsdell 2003). Consequently, we sought to
determine if the sensitivity of cardiac sodium
channels for brevetoxin congeners translates
into the differential cardiovascular effects
observable in embryonic sodium channel sub-
types in vivo. PbTx-3 adversely affected
development and survival in the medaka via a
myriad of effects. However, the distinct
cardiovascular responses to type A and type B
brevetoxins observed in our embryos (delayed
bradycardia and consistent tachycardia,
respectively) provided the most insight as to
the differing efficacies of these brevetoxin
congeners on ﬁnﬁsh development.
The toxins most commonly produced by
K. brevis are the unstable aldehyde PbTx-2 and
its stable alcohol PbTx-3. In puriﬁed samples
from log phase laboratory cultures, PbTx-2 is
the predominant toxin, and PbTx-3 is present
in approximately one-third the concentration
of PbTx-2 (Poli et al. 1986). In shellﬁsh tissue,
PbTx-3 remains largely intact, whereas PbTx-2
is rapidly converted to PbTx-3 and cysteine
conjugates (Plakas et al. 2002). Studies of
cockle (Austrovenus stutchburyi), mussel (Perna
canaliculus), and Pacific oyster (Crassostrea
gigas) tissues in New Zealand after an NSP
event indicated that the predominant breve-
toxin forms in the tissue were metabolites of
PbTx-2, including PbTx-3, brevetoxin-B1, cys-
teine conjugates, and fatty acid conjugates
(Ishida et al. 1995; Morohashi et al. 1999;
Murata et al. 1998). Differences were observed
in brevetoxin metabolite composition between
the mollusks wherein oysters contained more
PbTx-3 and cysteine conjugates and cockles
contained brevetoxin-B1 (Ishida et al. 1995).
However, some of the toxins found in cockle
tissues were more water soluble due to conju-
gation and would therefore be less likely to
accumulate in fatty ovarian tissue or eggs.
Adult fish exposed to brevetoxins during a
harmful algal bloom would be exposed mostly
to PbTx-2 and PbTx-3 (Poli et al. 1986). The
brevetoxin types that would most likely mobi-
lize into the oocytes of those fish would
include the metabolites of PbTx-2 in the
forms of PbTx-3 and, probably to a lesser
extent, more polar cysteine conjugates. Our
investigation of the developmental effects of
PbTx-3 in ﬁnﬁsh is therefore relevant in that
this brevetoxin congener is likely to preferen-
tially partition to the egg.
The differential accretion of brevetoxins
and their metabolites observed in mollusks
suggests that some unknown brevetoxin con-
geners may accumulate in fish tissues. Liver
tissue analysis of marine mammals exposed to
K. brevis blooms by radio immunoassay indi-
cated high levels of PbTx-3, and lesser
amounts of a brevetoxin metabolite that
coeluted with PbTx-2 (Van Dolah et al. 2003).
However, the brevetoxin metabolites identi-
fied by Dickey et al. (1999) and Poli et al.
(2000) in shellfish extracts were not found.
Future studies are needed to determine which
brevetoxin congeners accumulate in ﬁnﬁsh tis-
sues and, as relates to this study, those that
accumulate in ovarian tissue and eggs.
Natural blooms of K. brevis can be directly
associated with reduced larval recruitment due
to mortality of the adult ﬁsh population asso-
ciated with the bloom (Riley et al. 1989;
Warlen et al. 1998). This reduction in the
adult population could then lead to an indi-
rect delay in reproductive activity or fecundity
after a red tide event. A secondary indirect
effect of brevetoxin exposure, as demonstrated
by our microinjection studies, is a decrease in
the numbers of ﬁsh growing to reproductive
age as they are impacted by maternally trans-
ferred toxins during oogenesis. The accumu-
lation of lipid-soluble contaminants such as
o,p´-DDT has been demonstrated in finfish
(Ungerer and Thomas 1996a, 1996b). These
materials usually collect in muscle tissue and
viscera, including ovaries. They can be mobi-
lized during oogenesis and can therefore be
transferred to the oocytes. Once the lipophilic
materials are in the oocyte, following a fertil-
ization event, the developing embryo will
absorb them as part of its food source. During
this time, the embryos of oviparous species
are conﬁned to the internal environment des-
ignated by the egg’s chorion, wherein the ﬁsh
are nourished by an oil-laden yolk sack
around which it develops. Lipophilic contam-
inants such as DDT and polychlorinated
biphenyls have been demonstrated to accu-
mulate in eggs, and the amounts are propor-
tional to the contaminant body burden levels
of the adult fish (Miller 1993). Maternally
transferred organic contaminants have been
linked to population declines of lake trout,
where strong correlations have been deter-
mined to exist between egg content of organic
contaminants and hatching and fry survival
(Mac et al. 1993). These effects have been
experimentally replicated by egg microinjec-
tion of o,p´-DDT (Edmunds et al. 2000).
This model can also be applied to mimic the
maternal transfer of natural toxins such a
ciguatoxins and brevetoxins (Edmunds et al.
1999; Kimm-Brinson and Ramsdell 2001).
Brevetoxins have distinct effects on car-
diac sodium channels and have been reported
to have complex cardiovascular effects when
administered to mammals (Borison et al.
1985; Johnson et al. 1985). Heart develop-
ment occurs quickly in medaka, and weak
cardiac contractions are visible after 40 hr of
development. A fully functional heartbeat is
evident by 46 hr, and circulation occurs
approximately 8 hr later. Previous studies
have demonstrated effects of sodium channel
activators such as brevetoxins and ciguatoxins
on embryonic ﬁsh heart rates (Edmunds et al.
1999; Kimm-Brinson and Ramsdell 2001).
As demonstrated by Bottein Dechraoui and
Ramsdell (2003), type B brevetoxins have a
lower affinity for cardiac sodium channels
than type A brevetoxins. In contrast to our
results with PbTx-3, tachycardia was not
observed during development of medaka
embryos dosed with the type A brevetoxin,
PbTx-1 (Kimm-Brinson and Ramsdell 2001).
However, a delayed bradycardic response was
observed on day 6 in the PbTx-1–treated ﬁsh
(Figure 5). The time lag observed in cardio-
vascular effects of the two brevetoxin subtypes
suggests independent activation of the sympa-
thetic and parasympathetic nervous system by
each toxin. The effects of each respective
toxin on heart rate in ﬁsh embryos are com-
plicated due to the nature of a developmental
model being used in vivo. Cardiovascular
responses to brevetoxins have been observed
in rats, cats, and dogs thus far, but very few
aquatic models, and no marine models, have
been tested (Borison et al. 1985; Edmunds et
al. 1999; Johnson et al. 1985; Kimm-Brinson
and Ramsdell 2001; Templeton et al. 1989).
The results of these mammalian studies suggest
that brevetoxins elicit a Bezold-Jarisch effect in
which delayed bradycardia is observed
(Johnson et al. 1985; Poli et al. 1990). Delayed
bradycardia in these animals is triggered by
direct vagal nerve inputs to the heart, which
would arise from the activation of cholinergic
vagal efferents of the parasympathetic nervous
system. Mammalian studies indicated the
occurrence of delayed paroxysmal ventricular
tachycardia, or delayed arrhythmic tachycardia
(Poli et al. 1990). However, our medaka
embryos appeared to maintain consistently ele-
vated heart rates throughout development.
This suggests that the tachycardic effects of
PbTx-3 are elicited via another pathway, such
as indirect inputs from adrenergic efferents in
the sympathetic nervous system. However,
medaka heart rates were not monitored for sev-
eral hours at a time, so it is possible that their
tachycardic responses were not constant.
Additional microinjection studies of PbTx-2
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rate in fish embryos may help to further
explain the differences between type A and
type B brevetoxins observed in our in vitro and
in vivo assays.
Analyses of the expression of sodium chan-
nel subunits during development have demon-
strated that structural modifications are
required for the generation of mature skeletal
and cardiac voltage-gated sodium channels in
several models. The precursor forms of sodium
channels undergo several posttranslational alter-
ations and are eventually assembled into func-
tional channels (Catterall 1992; Schmid and
Guenther 1998). Expression of these channels
can be regulated during development by many
factors, including enervation and denervation
of muscle ﬁbers and coexpression of β subunits
with their α-subunit counterparts. It is there-
fore possible that the sodium channels trans-
fected into our human embryonic kidney cell
line (Bottein Dechraoui and Ramsdell 2003)
differed structurally from those found in
medaka embryonic tissues. Functional differ-
ences in sodium channels depend on the chan-
nel isoform and the tissue type in which the
channel is found. The mode of action of
sodium channel activators such as brevetoxins
and ciguatoxins in developing ﬁsh models has
not yet been determined. However, the toxins
are likely able to elicit their suite of effects on a
variety of sodium channel types as they become
expressed or down-regulated during the devel-
opmental process (Renaud et al. 1982).
Hyperkinetic twitching and spinal curva-
ture are commonly observed symptoms result-
ing from exposure to a voltage-gated sodium
channel activator such as brevetoxin or cigua-
toxin in medaka embryos (Edmunds et al.
1999; Kimm-Brinson and Ramsdell 2001).
Although the observed twitching response may
be due to direct activation of nerve cells, spinal
defects may be the result of secondary
responses to persistent activation of these cells
by the toxin. Similar responses have been
observed in the estuarine ﬁsh Fundulus hetero-
clitus when exposed to acetylcholinesterase
inhibitors, and in mammalian exposures to
anthropogenic toxins such as pyrethroids and
chlorinated hydrocarbons (Karen et al. 1998;
Ray 1991; Smith 1991). Products of both of
these compounds are used commercially as
insecticides. The inhibitory compounds
(acetylcholinesterase inhibitors) can be deleteri-
ous to developing embryos because acetyl-
choline plays a substantial role in neuronal
development and differentiation (Bigbee et al.
1999; Brimijoin and Koenigsberger 1999).
Inhibition of acetylcholinesterase activity
results in the constant activation of the acetyl-
choline receptor, which induces muscle cells to
use cellular calcium to induce persistent con-
tractions. The reallocation of calcium during
development to muscular contraction can
result in decreased bone integrity, which can in
turn translate into spinal and cranial defects
such as the curvatures observed in our medaka
studies (Edmunds et al. 1999; Karen et al.
1998; Kimm-Brinson and Ramsdell 2001).
Pyrethroids and chlorinated hydrocarbons are
sodium channel toxins that elicit their effects
as a secondary response to neuronal excitabil-
ity. Type I pyrethroid and DDT toxicity
involves a progressive development of whole
body tremors, uncoordinated twitching of the
dorsal muscles, and hyperexcitability (Ray
1991; Smith 1991). Furthermore, poisoning is
associated with spinal and brainstem excitabil-
ity. Persistent activation of the sodium chan-
nel in a developing vertebrate can potentially
have similar effects wherein hyperkinetic
twitching represents the muscular contractions
and tremors. Spinal and cranial defects were
regularly observed in medaka embryos
exposed to PbTx-1 and ciguatoxin (CTX-3C),
which are both more potent than PbTx-3.
The decreased occurrence of spinal curvature
in medaka embryos exposed to PbTx-3 may
be another example of the differential afﬁnity
of brevetoxin subtypes for sodium channels.
The activational effects of brevetoxins on
voltage-gated sodium channels during develop-
ment can inﬂuence the channels’ ability to set
off transcription and posttranslational modiﬁ-
cations (Schmid and Guenther 1998). These
molecular processes may be crucial to the dif-
ferentiation and development of nerve tissues.
Therefore, a neurotoxin such as PbTx-3 could
negatively affect development and embryonic
survival because it disrupts the differentiation
process. Based on the results of our three end
points (timed convulsions, heart rate, and
death), PbTx-3 adversely affects embryonic ﬁsh
development and is responsible for the
decreased numbers of ﬁsh surviving into subse-
quent age classes. Clumping erythrocytes and
morphologic abnormalities in embryos dosed
with PbTx-3 may be secondary cardiovascular
and nervous system responses to the activation
of voltage-gated sodium channels during devel-
opment. However, more studies on the mode
of action of these channel activators in devel-
oping models are needed. Many of the effects
observed in our medaka embryos dosed with
PbTx-3 are not seen in adult ﬁsh afﬂicted with
brevetoxin poisoning. For this reason, it is
important to understand the effects of such
toxins on an ecologic scale, not only on adult
ﬁsh but also on their offspring.
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